From maestrieating@wing.ncc.u-tokai.ac.jp  Wed May 23 09:57:09 2007
Return-Path: <maestrieating@wing.ncc.u-tokai.ac.jp>
Received: from mail1.cabelas.com ([91.140.145.9])
	by flax9.uwaterloo.ca (8.12.8/8.12.5) with ESMTP id l4NDv5qD025933
	for <gnitpick@speedy.uwaterloo.ca>; Wed, 23 May 2007 09:57:08 -0400
Received: from [150.7.242.12] by [91.140.145.9]; Wed, 23 May 2007 14:02:48 -0180
From: "Kem Hoke" <maestrieating@wing.ncc.u-tokai.ac.jp>
Date: Wed, 23 May 2007 14:02:48 -0180
To: <gnitpick@flax9.uwaterloo.ca>
Message-ID: <991920070523140248@maestrieating>
Subject: Warning

Dear Friend!

Have you ever heard about Oncology Med, Inc?     

Oncology Med  (OTC:ONCO) , Inc represents for your attention    

This is a public company engaged in the fulfillment of services     
related to the treatment of various cancers.     
It currently provides analysis and design of radiation treatment 
plans in order for radiation oncologists to administer radiation    
plans to cancer patients.   
Current services facilitate radiation treatment programs ranging  
from external beam radiation to more advanced radiation treatment   
technologies.   

